RSSCurrent Issue

Editorial Message and Issue Highlights–Vol. 15, No. 7–8, July-August 2018

Editorial Message and Issue Highlights–Vol. 15, No. 7–8, July-August 2018

| July 1, 2018 | 0 Comments

Dear Colleagues: Welcome to the July–August 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a report by Brennan et al titled, “Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eCSSRS™) Across Four Phase IIIb Clinical Trials in HIV-infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING).” Here, researchers assessed site perspectives on […]

Continue Reading

Worsening Choreoathetosis in Huntington’s Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report

Worsening Choreoathetosis in Huntington’s Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report

| July 1, 2018 | 0 Comments

By Clayton J. Hamilton, PharmD; Tysen K. Timmer, BA; Robert C. Munjal, MD; Fernando Cardozo-Pelaez, PhD; and Ian R. McGrane, PharmD Dr. Hamilton is with the Department of Pharmacy, Veteran’s Affairs Montana Medical Center-Fort Harrison, in Helena, Montana. Mr. Timmer is a third-year medical student at the University of Washington School of Medicine in Seattle, […]

Continue Reading

Atypical Neuroleptic Malignant Syndrome Precipitated By Clozapine And Quetiapine Overdose: A Diagnostic Challenge

Atypical Neuroleptic Malignant Syndrome Precipitated By Clozapine And Quetiapine Overdose: A Diagnostic Challenge

| July 1, 2018 | 0 Comments

By David Choon Liang Teo, MBBS, MRC Psych (UK), FAMS (Psychiatry); Hon Khuan Wong, MBBS; Sheng Neng Tan, MBBS, MMED (Psychiatry), FAMS (Psychiatry) Drs. Teo, Wong and Tan are with the Department of Psychological Medicine, Changi General Hospital, Singapore. Funding: No funding was provided for this article. Disclosures: The authors report no conflicts of interest […]

Continue Reading

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

| July 1, 2018 | 0 Comments

By Edmund G. Howe, MD, JD; Laney Rosenzweig, MS, LMRT; and Amy Shuman, MSW, LICSW, DCSW Dr. Howe is Professor of Psychiatry and Medicine, Uniformed Services University of the Health Sciences, in Bethesda, Maryland. Ms. Rosenzweig is with the Rosenzweig Center for Rapid Recovery in Orlando, Florida. Ms. Shuman is a psychological counselor at the […]

Continue Reading

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

| July 1, 2018 | 0 Comments

By Clare Brennan, DPT, MSPH; Hannah Whillis, MS; Choy Man, BS; Brian Wynne, MD; Vani Vannappagari, MBBS, MPH, PhD Dr. Brennan and and Ms. Man are with Clinical Development and Dr. Vannappagari is with Epidemiology and Real World Evidence at ViiV Healthcare in Research Triangle Park, North Carolina. Ms. Whillis was with GlaxoSmithKline, plc, in […]

Continue Reading

Risk Management: Licensing Board Complaints: What You Need To Know

Risk Management: Licensing Board Complaints: What You Need To Know

| July 1, 2018 | 0 Comments

By Ann McNary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The authors have no conflicts of interest relevant to the content of this article. Innov Clin Neurosci. 2018;15(7–8):35–37 This ongoing column is dedicated to providing information to […]

Continue Reading

Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine

Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine

| July 1, 2018 | 0 Comments

By Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Funding/financial disclosures: The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2018;15(7–8):11–14 Dear Editor: The second-generation antipsychotics (SGAs) that focus on dopamine-2 plus serotonin-2A receptor antagonism are first-line treatments in […]

Continue Reading

Letter to the Editor: Regarding Zika Microcephaly

Letter to the Editor: Regarding Zika Microcephaly

| July 1, 2018 | 0 Comments

By Beuy Joob, PhD, and Viroj Wiwanitkit, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: We read the article on zika microcephaly, which was published in the September-October 2017 issue of ICNS with a great interest.[1] Kolikonda […]

Continue Reading

Letter to the Editor: Can YouTube® Disseminate Dementia Knowledge to Sinagpore Chinese?

Letter to the Editor: Can YouTube® Disseminate Dementia Knowledge to Sinagpore Chinese?

| July 1, 2018 | 0 Comments

By Benjamin K.P. Woo, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: A community-based epidemiological survey has suggested that the prevalence of cognitive impairment and dementia is approximately 15.2 percent in Singapore Chinese.[1] While early […]

Continue Reading